[Skip to Content]
[Skip to Content Landing]
May 14, 1955


Author Affiliations

Orangeburg, N. Y.

Supervising Psychiatrist, Rockland State Hospital (Dr. Barsa), and Director, Research Facility, Rockland State Hospital, and Research Associate, Department of Neurology, College of Physicians and Surgeons, Columbia University (Dr. Kline).

JAMA. 1955;158(2):110-113. doi:10.1001/jama.1955.02960020016005

The root of the plant Rauwolfia serpentina Benth., a shrub indigenous to India, was used for centuries in native Indian medicine for the treatment of a wide variety of diseases, including mental disorders. The drug was introduced into the United States for its use in the management of hypertension. In 1952, Müller, Schlittler, and Bein1 identified a new crystalline alkaloid from the Rauwolfia root. This alkaloid, reserpine, appeared to be the chief active principle of Rauwolfia. In 1954, one of us (N. S. K.)2 reported on the use of the Rauwolfia whole root and reserpine in the treatment of various psychiatric disorders. The present study is an extension of a study3 made several months previously, based on the response of 150 chronically disturbed psychotics to reserpine therapy.

SUBJECTS  In a hospital building housing 740 chronically disturbed psychotic female patients, 200 of the most disturbed were selected regardless

First Page Preview View Large
First page PDF preview
First page PDF preview